ATRN-1051

N/A

Report date: 2024/06/13 16:53:49
NME

Base Information

Drug NameATRN-1051
Drug Alias NameATRN-1051ATRN-W1051APR-1051
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase WEE1 inhibitors
TargetsSerine/threonine-protein kinase WEE1
Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAtrin Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesAprea Therapeutics AbThe University Of Texas MD Anderson Cancer Center
Inactive CompaniesN/A
Active IndicationsSolid tumoursOvarian NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A